Pulmatrix Inc
(NASDAQ : PULM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PULM News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.02%70.471.0%$913.76m
AMGNAmgen Inc.
1.55%179.270.8%$649.20m
BIIBBiogen Inc.
1.64%293.340.9%$502.61m
CELGCelgene Corporation
0.62%124.271.0%$501.11m
INCYIncyte Corporation
1.55%135.162.3%$451.40m
REGNRegeneron Pharmaceuticals, Inc.
1.43%378.851.9%$338.90m
ALXNAlexion Pharmaceuticals, Inc.
1.48%133.192.0%$303.71m
TSROTESARO, Inc.
-3.96%180.9215.3%$161.36m
ILMNIllumina, Inc.
1.25%169.503.9%$158.96m
EXELExelixis, Inc.
3.97%22.395.5%$140.89m
VRTXVertex Pharmaceuticals Incorporated
0.43%91.012.6%$140.38m
CLVSClovis Oncology, Inc.
2.94%59.5116.4%$119.33m
BMRNBioMarin Pharmaceutical Inc.
0.39%94.303.9%$109.15m
AAgilent Technologies, Inc.
1.25%51.941.7%$107.79m
ACADACADIA Pharmaceuticals Inc.
-3.40%36.8219.0%$93.82m

Company Profile

Pulmatrix, Inc. is a clinical stage biotechnology company, which is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. It designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer in 2013 and is headquartered in Lexington, MA.